Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 228

1.

How to approach psychotic symptoms in a non-specialist setting.

Sami MB, Shiers D, Latif S, Bhattacharyya S.

BMJ. 2017 Nov 8;359:j4752. doi: 10.1136/bmj.j4752. No abstract available.

PMID:
29117973
2.

Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia.

Yohanna D, Cifu AS.

JAMA. 2017 Sep 19;318(11):1057-1058. doi: 10.1001/jama.2017.11112. No abstract available.

PMID:
28975291
3.

Evidence-Based Guidelines for the Pharmacologic Management of Methamphetamine Dependence, Relapse Prevention, Chronic Methamphetamine-Related, and Comorbid Psychiatric Disorders in Post-Acute Settings.

Härtel-Petri R, Krampe-Scheidler A, Braunwarth WD, Havemann-Reinecke U, Jeschke P, Looser W, Mühlig S, Schäfer I, Scherbaum N, Bothe L, Schaefer C, Hamdorf W.

Pharmacopsychiatry. 2017 May;50(3):96-104. doi: 10.1055/s-0043-105500. Epub 2017 Apr 26. Review.

PMID:
28445899
4.

Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.

Wilby KJ, Johnson EG, Johnson HE, Ensom MHH.

Ann Pharmacother. 2017 Aug;51(8):682-695. doi: 10.1177/1060028017703992. Epub 2017 Apr 6. Review.

PMID:
28385039
5.

Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness.

Lambert TJ, Reavley NJ, Jorm AF, Oakley Browne MA.

Aust N Z J Psychiatry. 2017 Apr;51(4):322-337. doi: 10.1177/0004867416686693. Epub 2017 Feb 1.

PMID:
28343435
6.

The Clinical High-Risk State for Psychosis (CHR-P), Version II.

Fusar-Poli P.

Schizophr Bull. 2017 Jan;43(1):44-47. doi: 10.1093/schbul/sbw158.

7.

Implementation of treatment guidelines for specialist mental health care.

Bighelli I, Ostuzzi G, Girlanda F, Cipriani A, Becker T, Koesters M, Barbui C.

Cochrane Database Syst Rev. 2016 Dec 15;12:CD009780. doi: 10.1002/14651858.CD009780.pub3. Review.

PMID:
27977851
8.

Validation of the National Institute of Neurological Disorders and Stroke Criteria for Psychosis in Parkinson Disease.

Gordon PC, Rocha MS, Kauark RG, Costa CD, de Oliveira MO, Godinho F, Borges V.

Am J Geriatr Psychiatry. 2017 Jan;25(1):73-80. doi: 10.1016/j.jagp.2016.08.011. Epub 2016 Aug 26.

PMID:
27742525
9.

Behavioral Disorders in Dementia: Appropriate Nondrug Interventions and Antipsychotic Use.

Reese TR, Thiel DJ, Cocker KE.

Am Fam Physician. 2016 Aug 15;94(4):276-82. Review.

10.

The importance of the physical health needs of people with psychotic disorders.

Suetani S, Scott JG, McGrath JJ.

Aust N Z J Psychiatry. 2017 Jan;51(1):94-95. doi: 10.1177/0004867416662151. Epub 2016 Aug 20. No abstract available.

PMID:
27521576
11.

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment.

Cooper SJ, Reynolds GP; With expert co-authors (in alphabetical order):, Barnes T, England E, Haddad PM, Heald A, Holt R, Lingford-Hughes A, Osborn D, McGowan O, Patel MX, Paton C, Reid P, Shiers D, Smith J.

J Psychopharmacol. 2016 Aug;30(8):717-48. doi: 10.1177/0269881116645254. Epub 2016 May 4.

PMID:
27147592
12.

Clinical Guidelines, psychosis and other gripping things.

Henderson S.

Aust N Z J Psychiatry. 2016 May;50(5):395-6. doi: 10.1177/0004867416644056. No abstract available.

PMID:
27106680
13.

Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era.

Alvarez-Jimenez M, O'Donoghue B, Thompson A, Gleeson JF, Bendall S, Gonzalez-Blanch C, Killackey E, Wunderink L, McGorry PD.

CNS Drugs. 2016 May;30(5):357-68. doi: 10.1007/s40263-016-0331-x. Review.

PMID:
27106296
14.

Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.

Lo TL, Warden M, He Y, Si T, Kalyanasundaram S, Thirunavukarasu M, Amir N, Hatim A, Bautista T, Lee C, Emsley R, Olivares J, Yang YK, Kongsakon R, Castle D.

Asia Pac Psychiatry. 2016 Jun;8(2):154-71. doi: 10.1111/appy.12234.

15.

Invited commentary on … NICE v. SIGN on psychosis and schizophrenia.

Taylor M, Perera U.

Br J Psychiatry. 2016 Apr;208(4):320-1. doi: 10.1192/bjp.bp.115.177584.

PMID:
27036697
16.

NICE v. SIGN on psychosis and schizophrenia: same roots, similar guidelines, different interpretations.

Kendall T, Whittington CJ, Kuipers E, Johnson S, Birchwood MJ, Marshall M, Morrison AP; NICE guideline development group for CG178.

Br J Psychiatry. 2016 Apr;208(4):316-9. doi: 10.1192/bjp.bp.115.170324.

PMID:
27036696
17.

Progress and Future Directions in Research on the Psychosis Prodrome: A Review for Clinicians.

Woodberry KA, Shapiro DI, Bryant C, Seidman LJ.

Harv Rev Psychiatry. 2016 Mar-Apr;24(2):87-103. doi: 10.1097/HRP.0000000000000109. Review.

18.

Emerging Role of Olanzapine for Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting.

DeRemer DL, Clemmons AB, Orr J, Clark SM, Gandhi AS.

Pharmacotherapy. 2016 Feb;36(2):218-29. doi: 10.1002/phar.1703. Review.

PMID:
26890915
19.

Getting to More Effective Weight Management in Antipsychotic-Treated Youth: A Survey of Barriers and Preferences.

Nicol G, Worsham E, Haire-Joshu D, Duncan A, Schweiger J, Yingling M, Lenze E.

Child Obes. 2016 Feb;12(1):70-6. doi: 10.1089/chi.2015.0076. Epub 2016 Jan 20.

20.

What are the disruptive symptoms of behavioral disorders after traumatic brain injury? A systematic review leading to recommendations for good practices.

Stéfan A, Mathé JF; SOFMER group.

Ann Phys Rehabil Med. 2016 Feb;59(1):5-17. doi: 10.1016/j.rehab.2015.11.002. Epub 2016 Jan 4. Review.

Supplemental Content

Loading ...
Support Center